MAGNEURON

Seeks to treat Parkinson’s disease by actuating the cells in our body with magnetic nanoparticles

Magneuron aims to treat Parkinson’s disease using bio-functionalised magnetic nanoparticles. These act as intracellular “hotspots” and will hijack the targeted cells’ signalling pathways in response to external magnetic fields.